The IPO of Paras Healthcare in 2026 is getting much interest from those investors who want to invest in India’s healthcare and hospital industries. Paras Healthcare Limited runs the chain of multispecialty hospitals that provide treatment to patients in many fields of medicine, such as cardiology, oncology, neurology and orthopaedics. In line with the rising demand of people for quality health care, the hospital business is becoming popular among the investors who want to invest in the healthcare industry. But before making an application for an IPO, one must get information about the business model of the company, its performance, valuation and risks involved.

Following is the analysis of Paras Healthcare IPO 2026 price band, lot size, GMP, financial performance and other important factors to be considered by the investors before making the application.

Paras Healthcare IPO 2026: Key Details

Here are the important details of the Paras Healthcare IPO.

The minimum investment value is based on the highest price band of ₹693 per share multiplied by 21 shares. It is advisable to consult the final prospectus for details on the issue conditions and application process.

Paras Healthcare IPO – What is it?

Paras Healthcare Ltd is a hospital provider which offers specialized and advanced healthcare services under the name of Paras Health. It operates multispecialty hospitals which offer medical services within different branches such as cardiology, oncology, neurology orthopedics and gastroenterology. Paras Healthcare earns money from medical consultations, surgery operations, diagnosis services, hospitalization services and other healthcare services. The key aspects of the company’s operations include patient acquisition, medical service quality, operation costs management and development of new hospitals. For investors, the efficiency in providing quality healthcare services with low operation costs will be an important factor.

Paras Healthcare IPO Price Band and Lot Size

For Paras Healthcare IPO, the price range will be ₹660 to ₹693 per equity share with a face value of ₹1 per share. The minimum lot size for investment will be 21 shares. An investor needs ₹14,553 to apply for one lot at the highest price range of ₹693, excluding the cost factor.

Paras Healthcare IPO Lot Size and Investment Amount

*Note: Amounts are calculated at the upper price band of ₹693 per share and exclude applicable charges.*

Retail Investors are eligible to apply for an amount that falls under the specified retail investment limit. S-HNI stands for Small Non-Institutional Investors while B-HNI stands for Big Non-Institutional Investors. The amount is not a guarantee for allotment. Investors should first check the applicable provisions for an IPO.

IPO GMP of Paras Healthcare

Grey Market Premium (GMP) is an unofficial measure that many investors follow prior to the listing of an IPO. It refers to the premium or discount at which the stocks are reportedly being sold in the unofficial market before the listing starts. If there is a positive GMP, it means that the listing of the stocks is expected to be good, while negative changes in the GMP could indicate poor market expectation. Still, GMP could quickly shift due to market dynamics.

If you are looking for the current GMP of Paras Healthcare IPO, you need to look up for the latest update rather than using outdated one. Any GMP that is reported should be confirmed and published after verification. Please bear in mind that GMP is an unofficial measure that does not guarantee any gain from listing. The actual listing price may differ from that one provided in the grey market. Investors should think about the company’s performance and prospects other than GMP.

Use of IPO Funds by Paras Healthcare

Paras Healthcare’s IPO is made up of a fresh issue of ₹500 crore and Offer for Sale of ₹950 crore. This difference is crucial to note here. Fresh issue money is received by the company whereas OFS is sold to raise money for the selling shareholders. In the offer documents, the company states that it will use the fresh issue funds in the way stated in the offer documents, including repayment/prepayment of borrowings, investments in specified subsidiaries for repayments and for general corporate purposes. While repayment of borrowings can help the company cut down its interest expenses and improve its financial position, investors need to understand whether the company has adequate funds or not for its debt repayments or whether it can generate enough cash from its business.

Financial Performance of Paras Healthcare

In FY 2025-26, Paras Healthcare Ltd. showed high financial performance by earning 23.9% more total income that amounted to ₹1,628.78 crore. Paras Healthcare Ltd. became profitable, as a profit after tax was earned amounting to ₹43.83 crore from a loss of ₹57.98 crore in the previous financial year. EBITDA saw a substantial increase of 100.9% to ₹335.58 crore. Besides, both the total assets and net worth of the company increased, which reflects its increased financial stability. Nevertheless, the borrowings also increased to ₹1,393.86 crore. Financial success in the past does not guarantee future success.

Paras Healthcare – Key Advantages Related to the IPO

1. Growing Demand for Healthcare Services
An increased demand for specialized healthcare treatment and hospitals can bring prospects for successful hospitals’ operators. Increased demand for advanced healthcare services can help fuel the development of the industry.

2. Specialized Healthcare Treatment
Paras Healthcare provides a range of medical treatments within different specializations. It helps to earn money from various departments due to diversified healthcare services.

3. Successful Branding of Hospitals
Paras Healthcare owns several hospitals under the Paras Health brand. Successful branding can increase trust of patients and promote relationships between doctors and other healthcare professionals.

4. Improved Financial Position
A company became profitable during the FY2026 after two-year period of losses. One should consider whether such trend will be continued in the future.

Risk Associated with Investing in Paras Healthcare IPO

There is always some risk associated with IPOs, which need to be assessed before investing.

• Debt risk: It is essential for hospitals to invest significantly in their infrastructure and medical facilities, which will increase the burden of existing debt.
• Operating expenses: Salary, medical equipment, maintenance and hospital infrastructure could influence the margins of profit.
• Competitors: Paras Healthcare is up against hospital chains and independent healthcare providers.
• Compliance issues: Hospitals have to comply with various regulatory aspects related to the health care industry.
• Sustainability of profitability: Despite the profit made by the company in FY2026, the investor needs to evaluate if the company can continue being profitable.
• Valuation risk: The investor needs to match the IPO price with the financial standing of the company.

Such information will aid the investors in making an informed decision.

Paras Healthcare IPO Review: Should You Apply?

The Paras Healthcare IPO offers you a chance to learn about India’s hospitals and healthcare industry. Some of the aspects which the investors may take into account include the hospital chain, its specialization, improved financial position, etc. But at the same time, the company’s debts, operating expenses, rivalry and profitability need to be taken into account.

Before applying to this IPO, the investor should analyze its valuation, financials and use of funds. Those seeking to make money from listing gain need to bear in mind that GMP is unofficial and does not guarantee any profits. It all depends on the investor’s financial needs and preferences.

To apply IPO or for more insights into market trends and investment opportunities, explore the resources available on Aetram.

FAQs

1. What services does Paras Healthcare Limited provide?
Paras Healthcare provides various medical services by running multispecialty hospitals under the Paras Health brand.

2. What is the minimum investment in the Paras Healthcare Limited IPO?
The minimum investment in the IPO is ₹14,553 for purchasing one lot of 21 shares at the upper price band without any charges.

3. What considerations need to be made when investing in the Paras Healthcare Limited IPO?
Some considerations are the company’s financial performance, borrowings, profitability, valuation, hospital network and future growth prospects.

4. Can the IPO GMP ensure listing gains for the Paras Healthcare Limited IPO?
No, the GMP cannot be considered a guaranteed return on investment since it is a subjective figure that represents the sentiment of the market.

5. What are some key risks in the Paras Healthcare Limited IPO?
The key risks in this case are borrowings, high cost of running hospitals, competition, regulatory requirements and profitability.

Disclaimer: This article is for educational purposes only and should not be considered investment advice. IPO investments are subject to market risks. Investors should read the official offer documents and consult a qualified financial adviser before making investment decisions.